NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma

Glioma is one of the most deadly types of brain cancer. As it is highly invasive, the prognosis for glioma patients remains dismal, with median survival rarely exceeding 16 months. Thus, developing a new prognostic biomarker for glioma and investigating its molecular mechanisms is necessary for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Guangrong, Han, Tao, Hu, Xiaomu, Yang, Zhou, Wang, Jin, Wen, Zhenyi, Li, Hengyu, Wang, Hongjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964493/
https://www.ncbi.nlm.nih.gov/pubmed/35372056
http://dx.doi.org/10.3389/fonc.2022.770628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964493/
https://www.ncbi.nlm.nih.gov/pubmed/35372056
http://dx.doi.org/10.3389/fonc.2022.770628

Ejemplares similares